The Edinburgh Lung Fibrosis Molecular Endotyping (ELFMEN) Study

Sponsor
University of Edinburgh
Study ID
NCT04016181
Status
Enrolling By Invitation

Conditions

  • Asbestosis
  • Idiopathic Pulmonary Fibrosis
  • Interstitial Lung Disease

Eligibility Criteria

Sex
ALL
Age
18 Years - 99 Years
Healthy Volunteers
Not accepted

Study Details

To prospectively study novel blood and lung biomarkers of disease activity in patients with IPF and other interstitial lung disease with the aims of prognostic modelling and disease clustering

Key Dates

First listed
Jul 11, 2019
Start date
Jun 14, 2007
Status verified
Jun 2026
Primary completion
Dec 31, 2026
Completion
Dec 1, 2036

Study Design

Enrollment
800 participants (estimated)

Primary Outcome Measure

Time to death (all cause) [ Time Frame: 15 years ]

Related Studies